Sex and diet shape fat tissue lipid profiles in obesity
In obesity, adipose tissue expands and accumulates, driving chronic inflammation. Previous research showed that sex steroid hormones can influence adipose tissue distribution, accumulation and immune responses in men and women. Changes in lipid composition in the visceral or gonadal white adipose tissue, or GWAT, during obesity can drive immune cell accumulation and boost proinflammatory mediators. Prior studies revealed sex differences in GWAT lipid species in obese mice, but scientists still do not understand the exact role of sex hormones in lipid composition.

In a recent study in the Journal of Lipid Research, Mita Varghese and a team of researchers at the University of Michigan investigated the GWAT lipid profiles in obese mice and mice with their gonads surgically removed, or GX mice. In an untargeted lipidomics analysis where they comprehensively analyzed all lipids, they found sex differences in several lipid species, such as phospholipids and sphingolipids, which are important cell membrane components. Obese males had significantly more precursor fatty acids than females and GX mice. Targeted analysis revealed sex differences in polyunsaturated fatty acids, or PUFAs, with males showing a significantly higher omega-6 to omega-3 ratio. They also found diet-driven differences in oxylipins, inflammation-linked lipids, which were higher in both male and female obese mice than in lean mice.
This study suggests that sex hormone levels and diet equally induce inflammation and changes in lipid composition in obesity. Future studies include further confirming lipid profiles and understanding how sex differences arise in obesity.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

How Alixorexton could transform narcolepsy treatment
A new investigational drug, alixorexton, targets the brain’s orexin system to restore wakefulness in people with narcolepsy type 1. Alkermes chemist Brian Raymer shares how molecular modeling turned a lab idea into a promising phase 3 therapy.

Phosphatases and pupils: A dual legacy
Yale professor Anton Bennett explores how protein tyrosine phosphatases shape disease, while building a legacy of mentorship that expands opportunity and fuels discovery in biochemistry and molecular biology.

Extracellular vesicles offer clues to cattle reproduction
Extracellular vesicles from pregnant cattle support embryo development better than laboratory models, highlighting their potential to improve reproductive efficiency in bovine embryo cultures. Read more about this recent MCP paper.

Proteomics reveals protein shifts in diabetic eye disease
Using proteomics, researchers identified protein changes in eye fluid that mark diabetic retinopathy progression and may serve as biomarkers for vision-threatening complications. Read more about this recent MCP paper.

Protein modifications drive lung cancer resistance
New assay enriches protein modifications in a single process, enabling detection of key changes in drug-resistant lung cancer cells that may guide future therapies.

How antigen-processing proteins shape immunity
Researchers show how components of the antigen processing machinery shape the immunopeptidome, offering insights into immune regulation and cancer biology.